Bryanna Norden
9PUBLICATIONS
181CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Jan 08, 2026
Acquired On-Target Alterations Drive Clinical Resistance to p53-Y220C Reactivators.Ferran Fece de la Cruz, Andreas Varkaris, Parasvi S Patel
|Dec 29, 2025
MAPK Pathway Mutations Emerge in Mutant IDH1 Inhibitor-Resistant Cholangiocarcinoma and Attenuate the IFN Response.Jinkai Wan, Hatice Duygu Saatcioglu, Haley Ellis
|Jan 02, 2025
TOP1 Mutations and Cross-Resistance to Antibody-Drug Conjugates in Patients with Metastatic Breast Cancer.Rachel O Abelman, Bogang Wu, Haley Barnes
|Mar 08, 2024
Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors.Ryan B Corcoran, Khanh T Do, Jeong E Kim
|Mar 04, 2024
The Irreversible FGFR Inhibitor KIN-3248 Overcomes FGFR2 Kinase Domain Mutations.Eranga R Balasooriya, Qibiao Wu, Haley Ellis
|Jan 18, 2024
Sotorasib Is a Pan-RASG12C Inhibitor Capable of Driving Clinical Response in NRASG12C Cancers.Douglas A Rubinson, Noritaka Tanaka, Ferran Fece de la Cruz
Pageof 2
Frequent Collaborators
9 joint publications
Ryan B Corcoran
4 joint publications
Dejan Juric
4 joint publications
Ferran Fece de la Cruz
4 joint publications
Haley Ellis
4 joint publications
Haley Barnes
3 joint publications
Aparna R Parikh
3 joint publications
Nabeel Bardeesy
3 joint publications
Andreas Varkaris
3 joint publications
Sara Ehnstrom
3 joint publications
Laura M Spring
